Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jeyarama S Ananta"'
Autor:
Abraham Joy, Tarik F. Massoud, Jeyarama S. Ananta, Thillai V. Sekar, Kira Foygel, Rammohan Devulapally, Kaushik Mishra, Rohith Bhethanabotla, Ramasamy Paulmurugan
1. Supplementary Results: Synthesis of S-(2-aminoethyl) methanesulfonothioate hydrobromide (III); Synthesis of HEA-b-EHA polymer; Synthesis and characterization of HEA-b-EHA micelles for orlistat loading, hydrodynamic size, polydispersity index and z
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4117b0c6f5efa5d823f988227406f894
https://doi.org/10.1158/1535-7163.22503196.v1
https://doi.org/10.1158/1535-7163.22503196.v1
Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing
Autor:
Malvina Páez, Meijie Tang, Fátima Cardozo, Sanny López, Jenna Weber, Yvalena Guillén, Jessica Kost, Jeyarama S Ananta, Muktha S Natrajan, César Cantero, Jesse J. Waggoner, Benjamin A. Pinsky, Laura Mendoza, Cynthia Bernal, Alejandra Rojas
Publikováno v:
Am J Trop Med Hyg
Antibody cross-reactivity confounds testing for dengue virus (DENV) and Zika virus (ZIKV). We evaluated anti-DENV and anti-ZIKV IgG detection using a multiplex serological platform (the pGOLD assay, Nirmidas, Palo Alto, CA) in patients from the Asunc
Autor:
Rayhaneh Afjei, Rammohan Devulapally, Husam A. Babikir, Ramasamy Paulmurugan, Meenakshi Malhotra, Jeyarama S. Ananta, Tarik F. Massoud, Thillai V. Sekar
Publikováno v:
Oncotarget
Temozolomide (TMZ) chemotherapy for glioblastoma (GBM) is generally well tolerated at standard doses but it can cause side effects. GBMs overexpress microRNA-21 and microRNA-10b, two known oncomiRs that promote cancer development, progression and res
Publikováno v:
Molecular Pharmaceutics. 13:3164-3175
Glioblastoma remains an aggressive brain malignancy with poor prognosis despite advances in multimodal therapy that include standard use of Temozolomide. MicroRNA-21 (miR-21) and microRNA-10b (miR-10b) are oncomiRs overexpressed in glioblastoma, prom
Autor:
Rammohan Devulapally, Thillai V. Sekar, Jeyarama S. Ananta, Abraham Joy, Tarik F. Massoud, Rohith Bhethanabotla, Ramasamy Paulmurugan, Kira Foygel, Kaushik Mishra
Publikováno v:
Molecular Cancer Therapeutics. 15:221-231
Triple-negative breast cancer (TNBC) is a recalcitrant malignancy with no available targeted therapy. Off-target effects and poor bioavailability of the FDA-approved antiobesity drug orlistat hinder its clinical translation as a repurposed new drug a
Publikováno v:
Neurological Research. 38:51-59
Current chemotherapies for brain glioblastoma do not achieve sufficient drug concentrations within tumors. Polymeric nanoparticles have useful physicochemical properties that make them promising as nanoparticle platforms for glioblastoma drug deliver
Publikováno v:
Molecular Pharmaceutics. 12:4509-4517
Glioblastoma (GBM) generally exhibits high IC50 values for its standard drug treatment, temozolomide (TMZ). MicroRNA-21 (miR-21) is an oncomiR overexpressed in GBM, thus controlling important aspects of glioma biology. We hypothesized that PLGA nanop
Autor:
Jeyarama S. Ananta, Irina V. Larina, Paolo Decuzzi, Andrew J. Coughlin, Jennifer L. West, Nanfu Deng
Publikováno v:
Small. 10:556-565
Multimodal imaging offers the potential to improve diagnosis and enhance the specificity of photothermal cancer therapy. Toward this goal, gadolinium-conjugated gold nanoshells are engineered and it is demonstrated that they enhance contrast for magn
Autor:
Jaehong Key, Paolo Decuzzi, Francesco Gentile, Meng Zhong, Melissa D. Landis, Jeyarama S. Ananta, Santosh Aryal
Publikováno v:
Biomaterials. 34:5402-5410
The in vivo performance of nanoparticles is affected by their size, shape and surface properties. Fabrication methods based on emulsification and nano-precipitation cannot control these features precisely and independently over multiple scales. Herei
Autor:
Clay Hopes, Bo Zhang, Jeyarama S Ananta, Su Zhao, Hao Wan, Benjamin A. Pinsky, Meijie Tang, Janaki Abeynayake, Shylaja Arulkumar, Hongjie Dai, Malaya K. Sahoo, Jesse J. Waggoner
Publikováno v:
Nature medicine. 23(5)
We developed a multiplexed assay on a plasmonic-gold platform for measuring IgG and IgA antibodies and IgG avidity against both Zika virus (ZIKV) and dengue virus (DENV) infections. In contrast to IgM cross-reactivity, IgG and IgA antibodies against